Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01816958 · ClinicalTrials.gov registry record
Neuromodulation to Facilitate the Effect of Ketamine
A clinical trial of Depression and Chronic Pain, sponsored by The Neuroscience Center.
- Completed
- Registry status
- 35
- Enrollment target
- 1
- Study location
NCT01816958: Completed study of Depression and Chronic Pain, sponsored by The Neuroscience Center.
NCT01816958 is a study of Depression and Chronic Pain that has completed, run by The Neuroscience Center. The registered enrollment target is 35 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01816958, a study of Depression and Chronic Pain, has completed, sponsored by The Neuroscience Center.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
application of external neuromodulation along with ketamine infusion.
Primary Outcome
treat in order to cause remission of disability
Conditions Studied
Interventions
- OTHER co-administration of TMS and infused ketamine
Study Locations (1)
Illinois
- The Neuroscience Center - Deerfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-11 |
What the finished NCT01816958 record still lists
NCT01816958 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which co-administration of TMS and infused ketamine is the first listed.
NCT01816958 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT01816958 about?
NCT01816958 is a clinical study titled "Neuromodulation to Facilitate the Effect of Ketamine". application of external neuromodulation along with ketamine infusion.
What is the current status of trial NCT01816958?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2011-01. Estimated completion is 2012-11.
What conditions does trial NCT01816958 study?
This clinical trial studies the following conditions: Depression, Chronic Pain, Substance Abuse.
What interventions are being tested in trial NCT01816958?
The interventions under investigation include: co-administration of TMS and infused ketamine (OTHER).
Who is sponsoring clinical trial NCT01816958?
This trial is sponsored by The Neuroscience Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01816958 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01816958's enrollment target sits among peer trials
35 541st of 679 higher than 135 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia